Chapter
Purdue Pharma executives plead guilty to misbranding Oxycontin
18:55 - 22:49 (03:54)
In a public statement, Purdue Pharma admitted that some employees made misleading statements about Oxycontin to healthcare professionals, leading three executives, including former CEO Michael Friedman, to plead guilty to misdemeanor charges of misbranding the drug.
Clips
The Sackler family and Purdue Pharma were not held accountable for wrongdoing until a lawsuit by the state of Virginia in 2007 for misbranding Oxycontin.
18:55 - 20:12 (01:17)
Sackler Family
Summary
The Sackler family and Purdue Pharma were not held accountable for wrongdoing until a lawsuit by the state of Virginia in 2007 for misbranding Oxycontin. Three executives pleaded guilty to misleading regulators, but there was some compensation for medical bills.
ChapterPurdue Pharma executives plead guilty to misbranding Oxycontin
EpisodePart Two: The Sackler Family: America's Deadliest Drug Dealers
PodcastBehind the Bastards
Purdue Pharma allegedly shielded family members from criminal charges related to the opioid epidemic by having non-family executives plead guilty instead and paying them millions.
20:12 - 22:49 (02:36)
Purdue Pharma
Summary
Purdue Pharma allegedly shielded family members from criminal charges related to the opioid epidemic by having non-family executives plead guilty instead and paying them millions.